<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Delayed ischemic neurological deficits (DIND) due to <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> remains a major cause of morbidity and mortality following aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (aSAH) </plain></SENT>
<SENT sid="1" pm="."><plain>Methods to prevent DIND remain limited both in safety and efficacy </plain></SENT>
<SENT sid="2" pm="."><plain>A novel intra-aortic dual balloon catheter (NeuroFlo™: CoAxia, Maple Grove, MN) is under investigation for treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, including DIND </plain></SENT>
<SENT sid="3" pm="."><plain>Because this technique does not require cerebral artery navigation, it may be useful as a bedside procedure, outside of the conventional angiography suite </plain></SENT>
<SENT sid="4" pm="."><plain>We report the first case of ultrasound-guided application of the NeuroFlo™ system at bedside in the Neurological Intensive Care Unit </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: A 52-year-old woman presented with Hunt Hess IV aSAH complicated by medically refractory <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Despite surgical clipping of her <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, the patient remained <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e>, failing maximal conventional medical therapy </plain></SENT>
<SENT sid="7" pm="."><plain>For that reason, the NeuroFlo™ system was deployed using two-dimensional, spectral and color-flow Doppler ultrasound guidance at the patient's bedside while maintaining <z:hpo ids='HP_0000001'>all</z:hpo> forms of cerebral blood flow monitoring </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The procedure was well tolerated and there was no complication </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Bedside application of the NeuroFlo™ system may be safely performed in <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>The NeuroFlo™ system is under investigation for treatment of refractory <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> to prevent delayed ischemic <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e> </plain></SENT>
</text></document>